By Staff
Monday, July 15, 2024 12:24 AM
CHICAGO—
Prevent Blindness, a nonprofit eye health and safety organization, hosted its 13th annual
Prevent Blindness Focus on Eye Health Summit on July 10 and 11, 2024. This year’s Summit included a variety of presentations related to the theme “Being Seen and Heard.” More than 800 registrants of the free, virtual and interactive two-day event were able to access an exhibitor hall, participate in “coffee chats” with fellow attendees and attend presentations on a variety of vision and public health topics led by leaders from across the country.
By Staff
Monday, July 15, 2024 12:21 AM
NEW YORK and BOCA RATON, Fla.—
Virtual Field, a provider of virtual visual field testing technology, together with
Professional Eye Care Associates of America (PECAA), a community of independent eyecare professionals, has announced a collaboration they said is aimed at increasing private practice access to in-practice eye exam technology.
By Staff
Monday, July 15, 2024 12:18 AM
RAHWAY, N.J.—
Merck, a research-intensive biopharmaceutical company known as MSD outside of the U.S. and Canada, has announced the completion of the acquisition of
Eyebiotech Limited, a privately held ophthalmology-focused biotechnology company.
By Staff
Monday, July 15, 2024 12:15 AM
PEMBROKE, N.C.—During a special meeting held on July 9, the Board of Trustees named Dr. Rich Castillo the founding dean of the school of optometry at the
University of North Carolina at Pembroke (UNCP).
By Staff
Friday, July 12, 2024 12:24 AM
EMERYVILLE, Calif.—
NovaBay Pharmaceuticals, Inc. (NYSE American: NBY), a developer of eyecare, skin care and wound care products, has announced preliminary net revenue of $2.4 million for the second quarter of 2024 and $5.0 million for the first half of 2024, primarily derived from the company’s eyecare products. Net revenue from the company’s eyecare products increased by 9 percent for both the second quarter and the first half of 2024 compared with the corresponding periods in 2023, the company noted. NovaBay also said it expects 2024 net revenue from the company’s eyecare products to be approximately $10 million.
By Staff
Friday, July 12, 2024 12:21 AM
KANSAS CITY, Mo.—
iOR Partners, a specialist in ophthalmic office-based surgery (OBS), announced that Lance J. Kugler, MD, has been named chairman of its strategic advisory board.
By Staff
Friday, July 12, 2024 12:18 AM
ALPHARETTA, Ga.—
Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company, has announced the appointment of Glenn C. Yiu, MD, PhD, professor of ophthalmology at the University of California, Davis, to its scientific advisory board.
By Staff
Friday, July 12, 2024 12:15 AM
ZURICH, Switzerland—
read on, a Swiss reading glasses design company, has appointed Prolens AG as a new distribution partner for its "read on light" reading glasses in Switzerland and Austria, to advance market growth and expansion in Europe, the company announced.
By Staff
Thursday, July 11, 2024 12:24 AM
SAN FRANCISCO—The
American Academy of Ophthalmology and the
North American Neuro-Ophthalmology Society have issued a response to a recent study that suggests patients taking semaglutide—the active ingredient in Ozempic and Wegovy—may be at higher risk of developing non-arteritic anterior ischemic optic neuropathy, or NAION, an eye condition that can cause blindness. The
study, conducted by researchers at Harvard University, was published on July 3, 2024 in
JAMA Ophthalmology. “Because diabetes is a known risk factor for NAION, patients with diabetes who qualify for GLP-1 treatment may be at higher risk for NAION to begin with," Andrew Lee, MD, clinical spokesperson for the American Academy of Ophthalmology and a neuro-ophthalmologist at Houston Methodist Hospital, told
VM.
By Staff
Thursday, July 11, 2024 12:21 AM
SAN CARLOS, Calif.—A new survey conducted by
XP Health and
Ipsos suggests that offering digital solutions with a hybrid approach can improve satisfaction with vision care.
By Staff
Thursday, July 11, 2024 12:18 AM
SUZHOU, China—The
Zeiss Group announced the opening of its new R&D and manufacturing site on July 8, 2024, in Suzhou Industrial Park (SIP). Covering an area of more than 13,000 square meters, the new site marks the group's first land purchase for its self-built project in China.
By Staff
Thursday, July 11, 2024 12:15 AM
NEW YORK—
DocGo Inc. (Nasdaq: DCGO), a provider of technology-enabled mobile health services, has announced its partnership with
Spect, a provider of comprehensive digital services for eye exam screenings, including diabetic retinopathy.
By Gwendolyn Plummer
Wednesday, July 10, 2024 8:30 AM
NEW YORK—On June 27, sunwear and summer enthusiasts alike celebrated National Sunglasses Day by breaking out their favorite pair of sunnies, snapping a selfie and posting on social media. National Sunglasses Day, which occurs on June 27 every year, is a fun and interactive holiday for everyone—but, most importantly, it creates the perfect opportunity for ECPs to remind patients and their communities just how important it is to keep our eyes protected from the sun. This National Sunglasses Day, independent ECPs took to local news stations, social media and more to educate the public and spread some sunny fun.
By Staff
Wednesday, July 10, 2024 12:24 AM
NEW YORK—The national average for gross revenue at ECP locations decreased last week, July 1–7, when compared with the previous week, at a rate of -36 index points due to last week’s July Fourth Independence Day holiday. That places gross revenue at a level -26 index points below where it was at this point in time (Week 27) when compared with last year (2023), -18 points below the same period in 2022, -12 points below 2021, -1 point below 2020 and 17 points above 2019, according to Jobson’s most recent Practice Performance Tracker.
By Staff
Wednesday, July 10, 2024 12:21 AM
NEW YORK—Medical experts are sounding the alarm about overprescribing antibiotics for children suffering from pink eye, according to a new study published in
JAMA Ophthalmology. Pink eye is an inflammation of the transparent membrane that lines the eyelid and eyeball.